Case Report: Renal Transplantation in Patients with Pre-existing Hypogammaglobulinemia

Scand J Immunol. 2017 Aug;86(2):113-117. doi: 10.1111/sji.12570.

Abstract

Hypogammaglobulinemia (HGG) is well-characterized as a common phenomenon after kidney transplantation. However, no reports of pre-existing HGG from kidney transplantation seem to be available. We have reviewed three patients who developed HGG prior to kidney transplantation, and all three were treated successfully with immunoglobulin replacement therapy before and after kidney transplantation. The kidney grafts were functioning at follow-up 1.5-8 years (mean: 3.6 years) after transplantation, and there were no diagnosed episodes of clinical rejections and no severe infection complications post-transplantation.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Agammaglobulinemia / complications
  • Agammaglobulinemia / diagnosis*
  • Agammaglobulinemia / drug therapy
  • Female
  • Graft Survival
  • Humans
  • Immunoglobulins / therapeutic use
  • Kidney Diseases / complications
  • Kidney Diseases / surgery*
  • Kidney Transplantation / methods*
  • Male
  • Middle Aged
  • Preoperative Period*
  • Retrospective Studies
  • Time Factors
  • Treatment Outcome

Substances

  • Immunoglobulins